Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
623
datasets available to search
ShareScore release 0.9.0
Dataset results
623 results for “hormonal therapy”
ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer.
ClinicalTrials.gov study NCT02681523. IPD Sharing: NO. Countries: 1. Publications: 1.
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
ClinicalTrials.gov study NCT04569747. IPD Sharing: YES. Countries: 1. Publications: 1.
Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy
ClinicalTrials.gov study NCT01800058. IPD Sharing: Not stated. Countries: 1. Publications: 22.
S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
ClinicalTrials.gov study NCT00433446. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
ClinicalTrials.gov study NCT00134056. IPD Sharing: YES. Countries: 1. Publications: 3.
Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
ClinicalTrials.gov study NCT02064582. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
ClinicalTrials.gov study NCT03219476. IPD Sharing: NO. Countries: 1. Publications: 1.
Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer
ClinicalTrials.gov study NCT00009945. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer
ClinicalTrials.gov study NCT02366130. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
ClinicalTrials.gov study NCT00016913. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov study NCT00004054. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
ClinicalTrials.gov study NCT00337077. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01498978. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer
ClinicalTrials.gov study NCT04600336. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
ClinicalTrials.gov study NCT00065442. IPD Sharing: Not stated. Countries: 2. Publications: 4.
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
ClinicalTrials.gov study NCT01807065. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
ClinicalTrials.gov study NCT00553410. IPD Sharing: Not stated. Countries: 20. Publications: 2.
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
ClinicalTrials.gov study NCT02040857. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to
ClinicalTrials.gov study NCT05526248. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy
ClinicalTrials.gov study NCT01302041. IPD Sharing: UNDECIDED. Countries: 4. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.